Multiple Sclerosis Trial, Recruiting ISRCTN10134617 Sponsor: Anglia Ruskin University Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

ISRCTN10134617
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older who have been diagnosed with a neurological condition affecting movement in the upper limbs (arm, hand, or shoulder), such as a stroke, traumatic brain injury, or multiple sclerosis
  • People whose arm movement falls within a specific range — not too severely limited, but affected enough to need rehabilitation — as measured by at least one of the following standardised assessments used by the trial team: a Fugl-Meyer Upper Extremity score between 20 and 50, the ability to move at least 5 blocks per minute in a standard grasping test, a minimum of 10 degrees of movement in both the shoulder and elbow, or a muscle stiffness score of 3 or below on a standard scale (confirm with trial site for details on which assessment applies)
  • People who are able to commit to a 6–8 week program involving 1 to 2 sessions per week of game-based rehabilitation
  • People who are able to give informed consent to participate, either on their own or with the support of a caregiver or legally authorised representative

Who may not be able to join:

  • People with unstable heart, breathing, bone, or neurological conditions — such as uncontrolled seizures or serious heart rhythm problems — that could pose a safety risk during the program
  • People with complete paralysis or very severe muscle stiffness in the affected arm that would prevent meaningful use of the rehabilitation system
  • People with severe motion sickness, significant vision problems, epilepsy triggered by flashing or moving visual images, or other conditions that would make the use of virtual reality or motion-tracking technology unsafe
  • People who are currently taking part in another research study or a separate rehabilitation program that could interfere with the results of this trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 10 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Anglia Ruskin University
Registry
ISRCTN registry
Start date
1 July 2025
Est. completion
1 July 2027

Where this trial is recruiting

England 🇬🇧 United Kingdom

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from the ISRCTN registry: 10 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ISRCTN ↗

Source: ISRCTN registry (isrctn.com), data processed 10 July 2026. ISRCTN metadata is CC0; contribution content is CC BY 4.0.